ONC Q1 2018 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q1 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$33M

Gross Profit

-$82M-251.1% margin

Operating Income

-$111M-340.5% margin

Net Income

-$105M-321.4% margin

EPS (Diluted)

$-2.08

QoQ Revenue Growth

+79.1%

Cash Flow

Operating Cash Flow

-$105M

Free Cash Flow

-$124M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$350M

Stockholders' Equity

$1.3B

Cash & Equivalents

$491M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$0	—
Gross Profit	-$82M	-$43M	-91.0%
Operating Income	-$111M	-$52M	-115.0%
Net Income	-$105M	-$51M	-106.6%